Chevallard Daniel R.
SEC insider (Form 3/4/5 filer). CIK 0001706176. Chief Financial Officer at LENZ Therapeutics, Inc. (LENZ). 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 27, 2026. Located in SOLANA BEACH, CA.
Companies Chevallard Daniel R. has filed insider reports for
- LENZ Therapeutics, Inc. (LENZ): Officer, Chief Financial Officer
Chevallard Daniel R.
CIK: 0001706176
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LENZ Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 27, 2026LENZ
LENZ Therapeutics, Inc.
PurchaseDirect7.5K shares at avg. $8.57$64K - Jan 2, 2026LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
84.2K shares- - Jan 2, 2026LENZ
LENZ Therapeutics, Inc.
AwardDirectRestricted Stock Unit
14K shares- - Nov 7, 2025LENZ
LENZ Therapeutics, Inc.
PurchaseDirect20 shares at avg. $22.71$454.2 - Nov 7, 2025LENZ
LENZ Therapeutics, Inc.
PurchaseDirect2.2K shares at avg. $22.76$50K - Jan 9, 2025LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
70.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 27, 2026 | LENZ LENZ Therapeutics, Inc. | Purchase | 7,500 | $8.57 | $64,275 | Direct |
| Jan 2, 2026 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 84,200 | - | - | Direct |
| Jan 2, 2026 | LENZ LENZ Therapeutics, Inc. | Award Restricted Stock Unit | 14,000 | - | - | Direct |
| Nov 7, 2025 | LENZ LENZ Therapeutics, Inc. | Purchase | 20 | $22.71 | $454 | Direct |
| Nov 7, 2025 | LENZ LENZ Therapeutics, Inc. | Purchase | 2,178 | $22.76 | $49,563 | Direct |
| Jan 9, 2025 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 70,444 | - | - | Direct |
1-6 of 6 transactions